Old Mission Capital LLC Ocular Therapeutix, Inc Transaction History

Old Mission Capital LLC

  • $33.1 Billion
  • Q3 2025

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2021

Aug 13, 2021
SELL
$13.43 - $19.16 $491,376 - $701,026
-36,588 Closed
0 $0
Q1 2021

May 14, 2021
BUY
$15.82 - $22.11 $195,978 - $273,898
12,388 Added 51.19%
36,588 $600,000
Q3 2020

Nov 16, 2020
BUY
$7.36 - $9.87 $178,112 - $238,853
24,200 New
24,200 $184,000

Others Institutions Holding OCUL

# of Institutions
236
Shares Held
158M
Call Options Held
1.24M
Put Options Held
423K
View Full List

About OCULAR THERAPEUTIX, INC

OCUL Quotes by TradingView
  • Ticker OCUL
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 76,966,896
  • Market Cap $875M
  • Description
  • Ocular Therapeutix, Inc., a biopharmaceutical company, focuses on the formulation, development, and commercialization of therapies for diseases and conditions of the eye using its bioresorbable hydrogel-based formulation technology. The company markets ReSure Sealant, an ophthalmic device to prevent wound leaks in corneal incisions following cat...
More about OCUL
Track This Portfolio

Track Old Mission Capital LLC Portfolio

Follow Old Mission Capital LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Old Mission Capital LLC, based on Form 13F filings with the SEC.

News

Stay updated on Old Mission Capital LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email